Pictured here, the Joseph DeSimone Research Group is now heavily focused on harnessing the fabrication technologies from the semiconductor industry to design high-performance, cost-effective vaccines and medicines.
Image Credit: Photo Courtesy of Joseph DeSimone
Joseph DeSimone and the team at Liquidia Technologies are developing engineered particle-based vaccines and therapeutics that have the potential to dramatically improve the quality of human life.
Image Credit: Photo Courtesy of Joseph DeSimone
This grid shows the range of particle sizes and shapes that can be achieved with DeSimones PRINT technology. PRINT enables the fabrication of particles with precise control over the shape, size, composition, and surface functionality.
Image Credit: Photo Courtesy of Joseph DeSimone
This image depicts helicopter-shaped particles interacting with a cell.
Image Credit: Photo Courtesy of Joseph DeSimone
Comments ( )